1
|
Turrión-Merino L, Salgüero-Fernández I. [Translated article] Dermatology and Gender Violence. Actas Dermo-Sifiliográficas 2024; 115:T102-T105. [PMID: 37918632 DOI: 10.1016/j.ad.2023.10.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 12/03/2022] [Accepted: 12/11/2022] [Indexed: 11/04/2023] Open
Affiliation(s)
- L Turrión-Merino
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
| | - I Salgüero-Fernández
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España
| |
Collapse
|
2
|
Turrión-Merino L, Salgüero-Fernández I. Dermatology and Gender Violence. Actas Dermosifiliogr 2024; 115:102-105. [PMID: 37321550 DOI: 10.1016/j.ad.2022.12.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 12/03/2022] [Accepted: 12/11/2022] [Indexed: 06/17/2023] Open
Affiliation(s)
- L Turrión-Merino
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
| | - I Salgüero-Fernández
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España
| |
Collapse
|
3
|
Moreno-Arrones OM, Béa-Ardebol S, Mayo-Martinez F, Pérez-Pastor G, Torres-Navarro I, Bonfill-Ortí M, Deza-Vargas LG, Ruiz-Salas V, Masferrer E, Feal C, Turrión-Merino L, Toll A, Yébenes M, Galiano-Mejías S, Jaka A, Ferrandiz-Pulido C, Florez A, Hernández-Hernández N, Fernández-de-Misa R, Rios-Buceta L, Sanmartin O. Sonidegib as a locally advanced basal cell carcinoma therapy in real-life clinical setting: a national multicentre study. Actas Dermosifiliogr 2023:S0001-7310(23)00318-6. [PMID: 37088285 DOI: 10.1016/j.ad.2023.04.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Revised: 04/16/2023] [Accepted: 04/18/2023] [Indexed: 04/25/2023] Open
Abstract
BACKGROUND Basal cell carcinoma (BCC) is the most prevalent cancer. A minority of BCCs have an aggressive behaviour (laBCC) and may require hedgehog pathway inhibitors such as sonidegib as its treatment. OBJECTIVE To describe the use of sonidegib in a large number of patients and provide more data on its real-life efficacy and safety profile. METHODS We conducted a retrospective and multicentric study that included patients treated with sonidegib. Epidemiological, effectiveness and safety data were collected. RESULTS A total of 82 patients with a mean age of 73.9 years were included. Ten patients had Gorlin syndrome. Median treatment duration was 6 months. Median follow-up duration was 34.2 months. Globally, 81.7% of the patients showed clinical improvement (52.4% partial response and 29.3% complete response), 12.2% clinical stability and 6.1% disease progression. There was no statistically significant difference in clinical improvement between the 24h and 48h sonidegib posology. After 6 months of treatment, 48.8% of the patients discontinued sonidegib. Prior vismodegib treatment and recurrent primary BCC were associated with a poorer response to sonidegib. At 6 months of treatment, 68.3% of the patients experienced at least one adverse effect. CONCLUSION Sonidegib shows good effectiveness and acceptable safety profile in usual clinical practice.
Collapse
Affiliation(s)
- O M Moreno-Arrones
- Dermatology Department, Ramon y Cajal University Hospital, University of Alcala, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
| | - S Béa-Ardebol
- Dermatology Department, Ramon y Cajal University Hospital, University of Alcala, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
| | - F Mayo-Martinez
- Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain
| | - G Pérez-Pastor
- Department of Dermatology, Consorci Hospital General Universitari de Valencia, Valencia, Spain
| | - I Torres-Navarro
- Department of Dermatology; Hospital Universitario y Politécnico La Fe, Valencia, Spain
| | - M Bonfill-Ortí
- Department of Dermatology; Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
| | - L G Deza-Vargas
- Department of Dermatology; Hospital del Mar, Barcelona, Spain
| | - V Ruiz-Salas
- Department of Dermatology Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - E Masferrer
- Dermatology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain
| | - C Feal
- Dermatology Department, Hospital de Pontevedra, Galicia, Spain
| | - L Turrión-Merino
- Dermatology Department, Hospital Puerta de Hierro, Madrid, Spain
| | - A Toll
- Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona (UB), Barcelona, Spain
| | - M Yébenes
- Department of Dermatology, Consorci Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain
| | - S Galiano-Mejías
- Department of Dermatology, Hospital Infanta Leonor, Madrid, España
| | - A Jaka
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
| | - C Ferrandiz-Pulido
- Department of Dermatology, Hospital Universitari Vall d'Hebron. Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - A Florez
- Dermatology Department, Hospital de Pontevedra, Galicia, Spain
| | - N Hernández-Hernández
- Department of Dermatology. Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
| | - R Fernández-de-Misa
- Department of Dermatology. Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
| | - L Rios-Buceta
- Dermatology Department, Ramon y Cajal University Hospital, University of Alcala, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
| | - O Sanmartin
- Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain
| |
Collapse
|
4
|
Turrión-Merino L, Alfageme-Roldán F, Salgüero-Fernández I, Martínez-Mera C, Roustan-Gullon G. Pseudoflujo en tumores anexiales cutáneos. Actas Dermo-Sifiliográficas 2020; 111:621-622. [DOI: 10.1016/j.ad.2019.01.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2018] [Revised: 11/22/2018] [Accepted: 01/12/2019] [Indexed: 10/24/2022] Open
|
5
|
Turrión-Merino L, Alfageme-Roldán F, Salgüero-Fernández I, Martínez-Mera C, Roustan-Gullon G. Pseudoflow in adnexal skin tumors. Actas Dermo-Sifiliográficas (English Edition) 2020. [DOI: 10.1016/j.adengl.2020.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|